[Development of thrombopoietin receptor agonists].
作者信息
Miyakawa Yoshitaka
出版信息
Rinsho Ketsueki. 2009 Oct;50(10):1434-43.
PMID:19915352
Abstract
摘要
相似文献
1
[Development of thrombopoietin receptor agonists].[血小板生成素受体激动剂的研发]
Rinsho Ketsueki. 2009 Oct;50(10):1434-43.
2
Venous thromboembolism and coagulation activity in patients with immune thrombocytopenia treated with thrombopoietin receptor agonists.血小板生成素受体激动剂治疗的免疫性血小板减少症患者的静脉血栓栓塞和凝血活性
Br J Haematol. 2012 Sep;158(6):811-4. doi: 10.1111/j.1365-2141.2012.09227.x. Epub 2012 Jul 23.
3
[Management of refractory ITP with thrombopoietin receptor agonists].[血小板生成素受体激动剂治疗难治性免疫性血小板减少症]
Rinsho Ketsueki. 2011 Aug;52(8):627-32.
4
Safety and efficacy of romiplostim in patients with eltrombopag-resistant or -intolerant immune thrombocytopenia.罗米司亭在艾曲泊帕耐药或不耐受的免疫性血小板减少症患者中的安全性和有效性。
Br J Haematol. 2013 Oct;163(2):286-9. doi: 10.1111/bjh.12483. Epub 2013 Jul 17.
5
Effectiveness of thrombopoietin-receptor agonists in the treatment of refractory immune thrombocytopenia associated to systemic lupus erythematosus.血小板生成素受体激动剂治疗系统性红斑狼疮相关难治性免疫性血小板减少症的疗效
J Rheumatol. 2014 Sep;41(9):1895-6. doi: 10.3899/jrheum.140080.
6
Thrombopoietin receptor activation, thrombopoietin mimetic drugs, and hereditary thrombocytosis: remarks on bone marrow fibrosis.
J Clin Oncol. 2010 Jul 1;28(19):e317-8. doi: 10.1200/JCO.2010.29.0387. Epub 2010 Jun 1.
7
Sequential treatment with thrombopoietin-receptor agonists (TPO-RAs) in immune thrombocytopenia (ITP): experience in our center.免疫性血小板减少症（ITP）中血小板生成素受体激动剂（TPO-RAs）的序贯治疗：我们中心的经验
Ann Hematol. 2017 Mar;96(3):507-508. doi: 10.1007/s00277-016-2896-3. Epub 2016 Dec 15.
8
Thrombopoietin receptor agonists in immune thrombocytopenia of less than 6 months duration.病程小于6个月的免疫性血小板减少症中的血小板生成素受体激动剂
Intern Med J. 2014 May;44(5):519-21. doi: 10.1111/imj.12406.
9
Thrombopoietin-receptor agonists for children with immune thrombocytopenia: a systematic review.用于免疫性血小板减少症患儿的血小板生成素受体激动剂：一项系统评价
Expert Opin Pharmacother. 2017 Oct;18(15):1543-1551. doi: 10.1080/14656566.2017.1373091. Epub 2017 Sep 4.
10
Thrombopoietin Receptor Agonists in Children with Immune Thrombocytopenia: A New Therapeutic Era.免疫性血小板减少症患儿的血小板生成素受体激动剂：一个新的治疗时代。
Endocr Metab Immune Disord Drug Targets. 2021;21(3):397-406. doi: 10.2174/1871530320666200531142244.
Zotero 插件